Medscape Medical Minute

Today on the Medscape Medical Minute: Only 7% of patients with cancer are getting guideline-recommended germline genetic testing; an experimental drug shows early promise in reducing liver fat in patients with NASH; and UK researchers report that long COVID symptoms are more severe in menopausal women.

In Today's Episode

• Huge Underuse of Germline Testing for Cancer Patients

• Akero Says NASH Drug Shown to Reduce Liver Fat by 65% in Some Patients

• Menopause and Long COVID: What Women Should Know

F. Perry Wilson, MD, MSCE, is an associate professor of medicine and director of the Clinical and Translational Research Accelerator at the Yale School of Medicine.

Medscape Medical News © 2023  WebMD, LLC

Send comments and news tips to news@medscape.net.

Cite this: Medscape Medical Minute - Medscape - Jun 08, 2023.